Solvias is a world leading CRO/CDMO headquartered in Switzerland with 6 sites across the U.S. & EU. Drawing on a proven 25-year track record of scientific excellence, we provide cGMP-compliant contract analytical services to help you bring safe and effective therapies to patients faster. Partner with us to gain access to a wide range of capabilities for characterization of biologics, ATMPs and small molecule drugs and method development, release testing and stability services. We also offer one of the largest ligand portfolios for catalytic transformations and a suite of related custom API synthesis and catalysis technology services.